Skip to main content
logo
Allied Corp. (ALID)
OTCMKTS · Delayed Price · Currency is USD
0.0111
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT

Achilles Therapeutics Revenue

Allied had revenue of $27.67K in the quarter ending November 30, 2024, with 45.33% growth. This brings the company's revenue in the last twelve months to $104.81K, up 387.26% year-over-year. In the fiscal year ending August 31, 2024, Allied had annual revenue of $96.18K with 33.41% growth.

Revenue (ttm)
104.81K
Revenue Growth
+387.26%
P/S Ratio
12.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.30M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 202496.18K24.08K33.41%
Aug 31, 202372.10K-93.50K-56.46%
Aug 31, 2022165.60K149.56K932.65%
Aug 31, 202116.04K--
Aug 31, 2020---
Aug 31, 2019 Pro Pro Pro
Jan 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
American Oncology Network1.76B
Northwest Biotherapeutics1.47M
Silence Therapeutics27.17M
BioStem Technologies332.45M
Revenue Rankings

Allied News

More News